Axovant's IPO

Axovant raised a round of funding on June 11, 2015. Investors include Public.

Axovant Sciences is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia, a condition characteri…

Articles about Axovant's IPO: